11 results
Pacemaker Coding Terminology
#Diagnosis #Cardiology #PPM #Pacemaker #LetterCode #Coding #Classification #Table #CoreEM
Pacemaker Coding ... PPM #Pacemaker #LetterCode ... #Coding #Classification ... #Table #CoreEM
The first three letters refer to chamber paced, chamber sensed, and response to sensed events. The
PPM #Pacemaker #LetterCode ... #Coding #Classification ... #Table
Hypokalemia - Differential Diagnosis
Poor Intake 
 - Starvation
 - Anorexia
GI Losses 
 - Vomiting / NG
- Anorexia GI ... tubular acidosis (Types ... and 2, but not type ... Low #Potassium #Table ... #Classification
Classification, Differential Diagnosis, and Features of Hyponatremia According to Volume Status 

Hypervolemic hypernatremia 
 - CHF
Classification, ... deficit - Salt-losing ... #Hyponatremia #Classification ... Differential #Diagnosis #Table
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
medications to treat Type ... effects include GI ... it works in the GI ... #Pharmacology #Dosing ... #Diabetes #DM2
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
Hypersensitivity Types ... Their Mechanisms Type ... or during hemolytic ... #Classification ... Diagnosis #Reactions #Table
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... including most type ... #TDD #Insulin #dosing ... endocrinology #diabetes #DM2
Hamartomatous Polyposis Syndromes - Peutz-Jeghers Syndrome (PJS), Juvenile Polyposis Syndrome (JPS), Cowden Syndrome (CS), Cronkhite-Canada (CC),
+ Hamartomas + GI ... polyps throughout GI ... testing if FHx, ≥ 2 GI ... - Varied polyp types ... Loss + Protein Losing
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
Calculations for Type ... calculations used in dosing ... patients with type ... SensitivityFactor #Type1 ... #Diabetes #DM1
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... known to have GI